Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients
NCT04218435
·
clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure NYHA Class IV
Heart Failure NYHA Class II
Interventions
DRUG:
Sacubitril / Valsartan Oral Tablet
Sponsor
Clinision